|
1
|
Dutrieux J, Maarifi G, Portilho DM, Arhel
NJ, Chelbi-Alix MK and Nisole S: PML/TRIM19-dependent inhibition of
retroviral reverse-transcription by Daxx. PLoS Pathog.
11:e10052802015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fagioli M, Alcalay M, Pandolfi PP,
Venturini L, Mencarelli A, Simeone A, Acampora D, Grignani F and
Pelicci PG: Alternative splicing of PML transcripts predicts
coexpression of several carboxy-terminally different protein
isoforms. Oncogene. 7:1083–1091. 1992.PubMed/NCBI
|
|
3
|
Sahin U, de Thé H and
Lallemand-Breitenbach V: PML nuclear bodies: assembly and oxidative
stress-sensitive sumoylation. Nucleus. 5:499–507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bernardi R, Papa A and Pandolfi PP:
Regulation of apoptosis by PML and the PML-NBs. Oncogene.
27:6299–6312. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Collins SJ: Retinoic acid receptors,
hematopoiesis and leukemogenesis. Curr Opin Hematol. 15:346–351.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jensen K, Shiels C and Freemont PS: PML
protein isoforms and the RBCC/TRIM motif. Oncogene. 20:7223–7233.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shen TH, Lin HK, Scaglioni PP, Yung TM and
Pandolfi PP: The mechanisms of PML-nuclear body formation. Mol
Cell. 24:331–339. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Duprez E, Saurin AJ, Desterro JM,
Lallemand-Breitenbach V, Howe K, Boddy MN, Solomon E, de Thé H, Hay
RT and Freemont PS: SUMO-1 modification of the acute promyelocytic
leukaemia protein PML: Implications for nuclear localisation. J
Cell Sci. 112:381–393. 1999.PubMed/NCBI
|
|
9
|
Zhong S, Müller S, Ronchetti S, Freemont
PS, Dejean A and Pandolfi PP: Role of SUMO-1-modified PML in
nuclear body formation. Blood. 95:2748–2752. 2000.PubMed/NCBI
|
|
10
|
Bernardi R and Pandolfi PP: Structure,
dynamics and functions of promyelocytic leukaemia nuclear bodies.
Nat Rev Mol Cell Biol. 8:1006–1016. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wethkamp N and Klempnauer KH: Daxx is a
transcriptional repressor of CCAAT/enhancer-binding protein β. J
Biol Chem. 284:28783–28794. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hofmann TG and Will H: Body language: The
function of PML nuclear bodies in apoptosis regulation. Cell Death
Differ. 10:1290–1299. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pan WW, Zhou JJ, Liu XM, Xu Y, Guo LJ, Yu
C, Shi QH and Fan HY: Death domain-associated protein DAXX promotes
ovarian cancer development and chemoresistance. J Biol Chem.
288:13620–13630. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Salomoni P, Dvorkina M and Michod D: Role
of the promyelocytic leukaemia protein in cell death regulation.
Cell Death Dis. 3:e2472012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
van Damme E, Laukens K, Dang TH and Van
Ostade X: A manually curated network of the PML nuclear body
interactome reveals an important role for PML-NBs in SUMOylation
dynamics. Int J Biol Sci. 6:51–67. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chen RH, Lee YR and Yuan WC: The role of
PML ubiquitination in human malignancies. J Biomed Sci. 19:812012.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen RH, Lee YR and Yuan WC: The role of
PML ubiquitination in human malignancies. J Biomed Sci. 19:812012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo A, Salomoni P, Luo J, Shih A, Zhong S,
Gu W and Pandolfi PP: The function of PML in p53-dependent
apoptosis. Nat Cell Biol. 2:730–736. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang ZG, Ruggero D, Ronchetti S, Zhong S,
Gaboli M, Rivi R and Pandolfi PP: PML is essential for multiple
apoptotic pathways. Nat Genet. 20:266–272. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pearson M, Carbone R, Sebastiani C, Cioce
M, Fagioli M, Saito S, Higashimoto Y, Appella E, Minucci S,
Pandolfi PP, et al: PML regulates p53 acetylation and premature
senescence induced by oncogenic Ras. Nature. 406:207–210. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Martin N, Benhamed M, Nacerddine K,
Demarque MD, van Lohuizen M, Dejean A and Bischof O: Physical and
functional interaction between PML and TBX2 in the establishment of
cellular senescence. EMBO J. 31:95–109. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen HY, Hu JY, Chen TH, Lin YC, Liu X,
Lin MY, Lang YD, Yen Y and Chen RH: KLHL39 suppresses colon cancer
metastasis by blocking KLHL20-mediated PML and DAPK ubiquitination.
Oncogene. 34:5141–5151. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hsu KS, Guan BJ, Cheng X, Guan D, Lam M,
Hatzoglou M and Kao HY: Translational control of PML contributes to
TNFα-induced apoptosis of MCF7 breast cancer cells and decreased
angiogenesis in HUVECs. Cell Death Differ. 23:469–483. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ito K, Carracedo A, Weiss D, Arai F, Ala
U, Avigan DE, Schafer ZT, Evans RM, Suda T, Lee CH, et al: A
PML-PPAR-δ pathway for fatty acid oxidation regulates hematopoietic
stem cell maintenance. Nat Med. 18:1350–1358. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Legartová S, Sehnalová P, Malyšková B,
Küntziger T, Collas P, Cmarko D, Raška I, Sorokin DV, Kozubek S and
Bártová E: Localized movement and levels of 53BP1protein are
changed by γ-irradiation in PML deficient cells. J Cell Biochem.
117:2583–2596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Van Colombo Ν, Gorp T, Parma G, Amant F,
Gatta G, Sessa C and Vergote I: Ovarian cancer. Crit Rev Oncol
Hematol. 60:159–179. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
